{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:06Z","timestamp":1791644406040,"version":"4.3.4"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We examined trends in histoplasmosis-associated hospitalizations in the United States using the 2001\u20132012 National (Nationwide) Inpatient Sample. An estimated 50 778 hospitalizations occurred, with significant increases in hospitalizations overall and in the proportion of hospitalizations associated with transplant, diabetes, and autoimmune conditions often treated with biologic therapies; therefore, histoplasmosis remains an important opportunistic infection.<\/jats:p>","DOI":"10.1093\/ofid\/ofv219","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T01:38:07Z","timestamp":1455586687000},"source":"Crossref","is-referenced-by-count":46,"title":["Histoplasmosis-Associated Hospitalizations in the United States, 2001\u20132012"],"prefix":"10.1093","volume":"3","author":[{"given":"Kaitlin","family":"Benedict","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Derado","sequence":"additional","affiliation":[{"name":"Biostatistics and Information Management Office, Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajal K.","family":"Mody","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"2020081005373548300_OFV219C1","article-title":"HCUP National Inpatient Sample 2012 and Nationwide Inpatient Sample 2001\u20132011. Healthcare Cost and Utilization Project (HCUP)"},{"key":"2020081005373548300_OFV219C2","article-title":"Trend Weights for 1993\u20132011 HCUP NIS Data. Healthcare Cost and Utilization Project (HCUP). 2015"},{"key":"2020081005373548300_OFV219C3","first-page":"1","article-title":"Trends in hospital utilization: United States, 1988\u201392","author":"Gillum","year":"1996","journal-title":"Vital Health Stat 13"},{"key":"2020081005373548300_OFV219C4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/500405","article-title":"Hospitalizations for endemic mycoses: a population-based national study","volume":"42","author":"Chu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020081005373548300_OFV219C5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3201\/eid1709.101987","article-title":"Geographic distribution of endemic fungal infections among older persons, United States","volume":"17","author":"Baddley","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2020081005373548300_OFV219C6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/cid\/ciu104","article-title":"Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae","volume":"58","author":"Novosad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081005373548300_OFV219C7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020081005373548300_OFV219C8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tid.12186","article-title":"Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"16","author":"Kauffman","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2020081005373548300_OFV219C9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199011000-00004","article-title":"Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature","volume":"69","author":"Wheat","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"2020081005373548300_OFV219C10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020081005373548300_OFV219C11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2325957413500535","article-title":"Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009","volume":"13","author":"Myint","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2020081005373548300_OFV219C12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020081005373548300_OFV219C13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3201\/eid2203.151117","article-title":"Epidemiology of histoplasmosis outbreaks in the United States, 1938\u20132013","volume":"22","author":"Benedict","year":"2016","journal-title":"Emerg Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/3\/1\/ofv219\/33600729\/ofv219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/3\/1\/ofv219\/33600729\/ofv219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:40:04Z","timestamp":1597052404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv219\/2460719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv219","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016]]},"published":{"date-parts":[[2016,1,1]]},"article-number":"ofv219"}}